NO20006022D0 - Rekombinant human interferon <beta>-1A (IFN-<beta>-1A)- formulering - Google Patents

Rekombinant human interferon <beta>-1A (IFN-<beta>-1A)- formulering

Info

Publication number
NO20006022D0
NO20006022D0 NO20006022A NO20006022A NO20006022D0 NO 20006022 D0 NO20006022 D0 NO 20006022D0 NO 20006022 A NO20006022 A NO 20006022A NO 20006022 A NO20006022 A NO 20006022A NO 20006022 D0 NO20006022 D0 NO 20006022D0
Authority
NO
Norway
Prior art keywords
beta
ifn
formulation
recombinant human
human interferon
Prior art date
Application number
NO20006022A
Other languages
English (en)
Other versions
NO20006022L (no
Inventor
John Alam
Mark Rogge
Susan Goelz
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of NO20006022D0 publication Critical patent/NO20006022D0/no
Publication of NO20006022L publication Critical patent/NO20006022L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20006022A 1998-05-29 2000-11-28 Rekombinant human interferon <beta>-1A (IFN-<beta>-1A)- formulering NO20006022L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/007242 WO1999062542A1 (en) 1998-05-29 1998-05-29 Recombinant human interferon beta-1a (ifn-beta-1a) formulation

Publications (2)

Publication Number Publication Date
NO20006022D0 true NO20006022D0 (no) 2000-11-28
NO20006022L NO20006022L (no) 2001-01-26

Family

ID=22266817

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006022A NO20006022L (no) 1998-05-29 2000-11-28 Rekombinant human interferon <beta>-1A (IFN-<beta>-1A)- formulering

Country Status (16)

Country Link
EP (1) EP1082132A1 (no)
JP (1) JP2002516874A (no)
KR (1) KR20010052454A (no)
CN (1) CN1299285A (no)
AU (1) AU8822598A (no)
BR (1) BR9815966A (no)
CA (1) CA2333063A1 (no)
EA (1) EA200001252A1 (no)
EE (1) EE200000694A (no)
HU (1) HUP0102241A2 (no)
IL (1) IL139933A0 (no)
IS (1) IS5732A (no)
NO (1) NO20006022L (no)
SK (1) SK17762000A3 (no)
TR (1) TR200003521T2 (no)
WO (1) WO1999062542A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025304A1 (en) * 2000-06-16 2002-02-28 Croze Edward M. Novel interferon for the treatment of multiple sclerosis
DE60130145T2 (de) * 2000-12-21 2008-05-15 Resuscitation Technologies, LLC, Santa Monica Stabile t3 zusammensetzungen und ihre anwendung
CN1325651C (zh) * 2001-05-24 2007-07-11 大连金威基因技术有限公司 人重组乙型干扰素的高效表达及其应用
CN1535724B (zh) * 2003-04-23 2012-09-05 北京金迪克生物技术研究所 重组人干扰素在制备预防严重性急性呼吸道综合征的药物的用途
EP2224913B1 (en) * 2007-12-04 2014-10-15 Remedy Pharmaceuticals, Inc. Improved formulations and methods for lyophilization and lyophilates provided thereby
WO2022056233A1 (en) * 2020-09-12 2022-03-17 Academia Sinica Re-folded human serum albumin and use thereof for anti-tumor

Also Published As

Publication number Publication date
IS5732A (is) 2000-11-24
IL139933A0 (en) 2002-02-10
HUP0102241A2 (hu) 2001-10-28
SK17762000A3 (sk) 2001-07-10
BR9815966A (pt) 2001-02-28
WO1999062542A1 (en) 1999-12-09
EE200000694A (et) 2002-06-17
TR200003521T2 (tr) 2001-07-23
CA2333063A1 (en) 1999-12-09
JP2002516874A (ja) 2002-06-11
KR20010052454A (ko) 2001-06-25
EP1082132A1 (en) 2001-03-14
NO20006022L (no) 2001-01-26
AU8822598A (en) 1999-12-20
CN1299285A (zh) 2001-06-13
EA200001252A1 (ru) 2001-06-25

Similar Documents

Publication Publication Date Title
LU91598I2 (fr) Romiplostim (Nplate-romiplostim)
DE69920011D1 (de) Rekombinanter venezolanische-equine-pferdeenzephalitis-virusimpstoff
EP1218408A4 (en) 32 HUMAN, SECRETED PROTEINS
EP1212343A4 (en) 52 HUMAN SECRETED PROTEINS
EP1181390A4 (en) 27 HUMAN SECRETED PROTEINS
NO992667D0 (no) Human &lt;beta&gt;2-integrin-&lt;alfa&gt;-subenhet
EP1212342A4 (en) 18 HUMAN-SECRETED PROTEINS
EP1230360A4 (en) 15 HUMAN SECRETED PROTEINS
EP1226231A4 (en) 19 HUMAN SECRETED PROTEINS
EP1175438A4 (en) 62 HUMANE SECRETIED PROTEINS
EP1192176A4 (en) 49 HUMAN SECRETED PROTEINS
EP1192278A4 (en) 48 HUMAN SECRETED PROTEINS
EP1175439A4 (en) 49 HUMANE SECRETIED PROTEINS
EP1159284A4 (en) 33 HUMAN SECRETARY PROTEINS
EP1189917A4 (en) 48 HUMAN SECRETED PROTEINS
NO20006022D0 (no) Rekombinant human interferon &lt;beta&gt;-1A (IFN-&lt;beta&gt;-1A)- formulering
AU4202699A (en) Human socs proteins
DE69822559D1 (de) Siliconzusammensetzung
EP1185543A4 (en) 50 HUMAN-SECRETED PROTEINS
EP1173477A4 (en) 49 HUMAN SECRETED PROTEINS
EP1224201A4 (en) 32 HUMAN SECRETED PROTEINS
EP1203005A4 (en) 25 HUMAN SECRETED PROTEINS
ATE381618T1 (de) Polypeptidhormon phosphatonin
EP1171460A4 (en) 48 HUMAN SECRETED PROTEINS
EP1165828A4 (en) 50 HUMAN SECRETED PROTEINS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application